Product Program year 2019 Source: CMS Open Payments

Flulaval

Biological Vaccines

NDC 19515-894-41

Open in the dashboard

General payments

$34,606

1,678 payments

Research payments

$0

0 payments

Through program year 2019, $34,606 in general payments and $0 in research payments were reported against Flulaval (Vaccines).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2019 General $34,606 1,678

Breakdown

Who paid General payments · program year 2019
  1. GlaxoSmithKline, LLC. $34,606 1,678 payments
Top recipients General payments · program year 2019
  1. Childrens Hospital Colorado Teaching hospital · CO $3,750 11% · 2 payments
  2. Childrens Hospital Corporation Teaching hospital · MA $2,000 6% · 1 payment
  3. Childrens Mercy Hospital Teaching hospital · MO $1,500 4% · 1 payment
  4. Wyoming Medical Center Teaching hospital · WY $1,000 3% · 1 payment
  5. Ohsu Hospital And Clinics Teaching hospital · OR $850 2% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Pediatrics $11,697 47% · 619 practitioners
  2. Family Medicine $6,228 25% · 374 practitioners
  3. Internal Medicine $4,003 16% · 225 practitioners
  4. Adolescent Medicine Pediatrics $1,043 4% · 46 practitioners
  5. Cardiovascular Disease Internal Medicine $212 <1% · 11 practitioners

The top 5 of 49 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. New York $5,459 16% · 230 recipients
  2. Colorado $4,057 12% · 23 recipients
  3. Missouri $3,711 11% · 121 recipients
  4. Texas $2,461 7% · 154 recipients
  5. California $2,405 7% · 106 recipients

The top 5 of 45 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

1,678 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record